Novel druggable regions in set domain proteins and methods of using the same
CA 2494837 A1 · Owner: Cheng, Xiaodong · Inventors: Zhang, Xing; Cheng, Xiaodong
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to novel druggable regions discovered in histone H3 lysine methyltransferase DIM-5, which is a SET domain protein. The present invention further relates to methods of using the druggable regions to screen potential candidate therapeutics for diseases in which the activity of SET domain proteins are implicated, for example anti-cancer/anti-proliferative , agents or anti-fungal agents.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 6, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 6, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 6, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.